Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Q32 Bio (QTTB) Divestments (2022)

Q32 Bio (QTTB) has 1 years of Divestments data on record, last reported at $130.0 million in Q1 2022.

  • For Q1 2022, Divestments changed N/A year-over-year to $130.0 million; the TTM value through Dec 2022 reached $130.0 million, changed N/A, while the annual FY2022 figure was $130.0 million, N/A changed from the prior year.
  • Divestments reached $130.0 million in Q1 2022 per QTTB's latest filing.
  • Across five years, Divestments topped out at $130.0 million in Q1 2022 and bottomed at $130.0 million in Q1 2022.